Concepedia

Paul Beswick

PB

Statistics

Publications

33

Citations

1.5K

H-Index

23

Active since

1984

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Bicycle Therapeutics (United Kingdom)

University of Sussex

University of Cambridge

University of Hertfordshire

Paul Beswick is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1984–2025

33

Publications

33

Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors

Oliver N. F. King, Xuan Shirley Li, Masaaki Sakurai et al. · PLoS ONE · 2010 · 224 citations · Full text

, , +13

Chelation‐Controlled Intermolecular Hydroacylation: Direct Addition of Alkyl Aldehydes to Functionalized Alkenes

Michael C. Willis, Steven J. McNally, Paul Beswick · Angewandte Chemie International Edition · 2003 · 134 citations

, , +10

Novel 1, 2, 4-oxadiazoles as potent and selective histamine H3 receptor antagonists

J. W. CLITHEROW, Paul Beswick, W Irving et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 107 citations

, , +10

Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of Cancer

Gemma Mudd, Heather S. Scott, Liuhong Chen et al. · Journal of Medicinal Chemistry · 2022 · 90 citations · Full text

, , +17

Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor

Muna Abdi, Paul Beswick, Andy Billinton et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 70 citations · Full text

, , +13

1–5 of 33